Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

AI-Powered Smart PCR System to Revolutionize Clinical Diagnostics

By LabMedica International staff writers
Posted on 23 Oct 2024

Polymerase chain reaction (PCR) is a widely used laboratory technique for amplifying or copying small segments of genetic material, applicable in areas such as DNA fingerprinting, diagnosing genetic disorders, and detecting pathogens like COVID-19. More...

From medical diagnostics to forensic testing and national security, PCR DNA profiling has transformed high-throughput sampling in the 21st century, yet little has changed since its inception in the 1980s. Traditional DNA amplification requires that all parameters be established before the process begins, overlooking the variations that may exist between samples and conditions. Even minor enhancements in PCR performance could significantly affect the hundreds of thousands of DNA samples amplified each year, especially when dealing with degraded samples. Researchers have now made advancements in critical DNA testing by incorporating machine learning into DNA profiling.

The new research by experts at Flinders University (Bedford Park, SA, Australia) revealed substantial improvements in both the quality of DNA profiling and the efficiency of PCR cycling conditions through the application of artificial intelligence (AI) techniques. In their study, the researchers employed machine learning to develop new "smart PCR" systems, focusing on large-scale potential modifications and quicker cycling conditions for faster and more accurate results. Their findings, published in an article in Genes, demonstrated how to set up a system that enables a PCR process to provide real-time feedback, allowing a machine-learning algorithm to make instantaneous adjustments to PCR conditions.

By leveraging advancements in machine learning and sensor technology, the researchers have transformed the PCR process from a one-size-fits-all approach to a tailored and optimized experience, achieving higher quality and greater quantities of DNA in less time than previously possible. According to the researchers, if harnessed effectively, AI and machine learning could significantly enhance the sensitivity of PCR testing. With continued research, these AI-ML methodologies hold promise for improving the quality of trace DNA samples.

“Our system has the potential to overcome challenges that have hindered forensic scientists for decades, especially with trace, inhibited, and degraded samples,” said College of Science and Engineering PhD candidate Caitlin McDonald, who led the study. “By intelligently optimizing PCR for a wide variety of sample types, it can dramatically enhance amplification success, delivering more reliable results in even the most complex cases.”


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.